Genexine Market Cap

Genexine has a market cap or net worth of 229.22 billion as of December 5, 2025. Its market cap has decreased by -27.48% in one year.

Market Cap

229.22B

Enterprise Value

n/a

Revenue

5.81B

Ranking

n/a

PE Ratio

n/a

Stock Price

5,040.00

Market Cap Chart

Since September 15, 2009, Genexine's market cap has increased from 109.02B to 229.22B, an increase of 110.25%. That is a compound annual growth rate of 4.68%.

Market Cap History

Date	Market Cap	% Change
Dec 5, 2025	229.22B	-5.62%
Dec 30, 2024	242.86B	-40.82%
Dec 28, 2023	410.35B	-12.73%
Dec 29, 2022	470.21B	-67.78%
Dec 30, 2021	1,459.20B	-52.47%
Dec 30, 2020	3,069.93B	106.72%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	76.57T
Celltrion	40.30T
ALTEOGEN	27.86T
ABL Bio	11.08T
SK Biopharmaceuticals	10.53T
Yuhan	8,911.91B
LigaChem Biosciences	6,907.33B
Peptron	6,668.76B

Market Cap Rankings